" class="no-js "lang="en-US"> Pneumagen - Medtech Alert
Thursday, September 04, 2025
Pneumagen | Pharmtech Focus

Pneumagen

About Pneumagen

Pneumagen

PNEUMAGEN LIMITED is a biotechnology company based out of St. Andrews, Scotland

Related Story

Pneumagen Further Strengthens IP Protection for Lead Product Neumifil with Granting of US Composition of Matter Patent

April 19 2023

Pneumagen, a clinical-stage biotech company developing Neumifil, a broad-spectrum antiviral, intranasal drug for the prophylaxis […]

Pneumagen Raises £3.8 million to Advance the Phase II Clinical Development of Neumifil, a Pan-antiviral, Intranasal Drug for the Prophylaxis and Treatment of Viral Respiratory Tract Infections (RTIs)

January 19 2022

Pneumagen, a clinical stage biotech company developing Neumifil, a pan-antiviral, intranasal drug for the prophylaxis […]